Cargando…
Polo-like kinase 4 (Plk4) potentiates anoikis-resistance of p53KO mammary epithelial cells by inducing a hybrid EMT phenotype
Polo-like kinase 4 (Plk4), the major regulator of centriole biogenesis, has emerged as a putative therapeutic target in cancer due to its abnormal expression in human carcinomas, leading to centrosome number deregulation, mitotic defects and chromosomal instability. Moreover, Plk4 deregulation promo...
Autores principales: | Fonseca, Irina, Horta, Cíntia, Ribeiro, Ana Sofia, Sousa, Barbara, Marteil, Gaëlle, Bettencourt-Dias, Mónica, Paredes, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935921/ https://www.ncbi.nlm.nih.gov/pubmed/36797240 http://dx.doi.org/10.1038/s41419-023-05618-1 |
Ejemplares similares
-
Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022) -
STIL binding to Polo-box 3 of PLK4 regulates centriole duplication
por: Arquint, Christian, et al.
Publicado: (2015) -
Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB)
por: Bailey, Anders W., et al.
Publicado: (2018) -
Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
por: Zhang, Xiaoyang, et al.
Publicado: (2021) -
Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice
por: Ward, Alejandra, et al.
Publicado: (2011)